Log in to save to my catalogue

Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intesti...

Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intesti...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5eb6b389fe5147e39c08cf643fd1bdcd

Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis

About this item

Full title

Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2021-05, Vol.12 (1), p.3105-17, Article 3105

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Environmental factors, mucosal permeability and defective immunoregulation drive overactive immunity to a subset of resident intestinal bacteria that mediate multiple inflammatory conditions. GUT-103 and GUT-108, live biotherapeutic products rationally designed to complement missing or underrepresented functions in the dysbiotic microbiome of IBD p...

Alternative Titles

Full title

Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5eb6b389fe5147e39c08cf643fd1bdcd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5eb6b389fe5147e39c08cf643fd1bdcd

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-021-23460-x

How to access this item